Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

NCT00109603 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Dyslipidemia
Hyperlipidemia
Hypercholesterolemia
Hypertriglyceridemia

Interventions

DRUG: Tenofovir disoproxil fumarate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)